CLINICAL_TRIALS
trial_result
· 2015-12-02
Clinical Trial Update: A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016) [Phase 2]
Summary
A Phase 2 study of MK0359 in patients with chronic obstructive pulmonary disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED